Catalog Number 115309 |
Device Problem
Device Contamination with Chemical or Other Material (2944)
|
Patient Problem
No Patient Involvement (2645)
|
Event Date 11/18/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Prismaflex st100 set ckt has been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that during priming with a prismaflex st100, a particle in the set (filter pot) was observed.There was no patient involvement.No additional information is available.
|
|
Manufacturer Narrative
|
H10: the actual device was available and a photograph of the sample was provided for evaluation.The visual inspection of the provided picture showed the presence of a whitish precipitate in the access circuit of the set.The reported condition was verified.There was no visible particulate matter or precipitate in any of the lines of the actual set , nor in the bag of dextrose 5% priming solution.The whitish precipitate observed on the picture provided by the customer had dissolved since the event occurred.An infra-red analysis of liquid collected from the set¿s access line and anticoagulant line and from the returned dextrose 5% priming solution bag was conducted and the result was inconclusive.A test was performed to confirm the absence of futhan (nafamostat mesylate) in the sample and the sample didn't contained futhan.The reported condition was not verified in the sample.The cause could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Search Alerts/Recalls
|